3i Group (LON:III – Get Free Report) insider Simon Borrows bought 50,000 shares of the stock in a transaction on Thursday, May 21st. The stock was purchased at an average price of GBX 2,229 per share, for a total transaction of £1,114,500.
3i Group Price Performance
Shares of III traded up GBX 58 during mid-day trading on Friday, reaching GBX 2,308. 27,162,576 shares of the stock traded hands, compared to its average volume of 28,106,535. The firm has a fifty day moving average price of GBX 2,616.03 and a 200 day moving average price of GBX 3,074.58. The company has a market cap of £23.49 billion, a price-to-earnings ratio of 3.56, a price-to-earnings-growth ratio of -0.35 and a beta of 1.15. The company has a current ratio of 131.80, a quick ratio of 0.09 and a debt-to-equity ratio of 4.08. 3i Group has a 1 year low of GBX 1,825 and a 1 year high of GBX 4,497.
3i Group (LON:III – Get Free Report) last issued its quarterly earnings data on Thursday, May 14th. The company reported GBX 539.40 earnings per share (EPS) for the quarter. The company had revenue of GBX 549.60 billion for the quarter. 3i Group had a return on equity of 17.91% and a net margin of 1,236.92%. As a group, equities research analysts predict that 3i Group will post 622.7106227 earnings per share for the current year.
Analyst Upgrades and Downgrades
View Our Latest Stock Analysis on III
About 3i Group
3i is an investment company specialising in Private Equity and Infrastructure. We invest in mid-market companies headquartered in Europe and North America.
We generate attractive returns for our shareholders and co-investors by investing in private equity and infrastructure assets.
As proprietary capital investors we have a long-term, responsible approach.
We aim to compound value through thoughtful origination, disciplined investment and active management of our assets, driving sustainable growth in our investment companies.
Featured Stories
- Five stocks we like better than 3i Group
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
- Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half
- Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
Receive News & Ratings for 3i Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 3i Group and related companies with MarketBeat.com's FREE daily email newsletter.
